Inventor
VELLINGA JORT
NL15 patents
⚠️ This page may combine multiple inventors who share the name “VELLINGA JORT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN VACCINES & PREVENTION BV
11 patentsUS10369214B2Aug 6, 2019
Synthetic human immunodeficiency virus (HIV) envelope antigen, vectors, and compositions thereof
JANSSEN VACCINES & PREVENTION BV5 citations80
US10744196B2Aug 18, 2020
HPV vaccines
JANSSEN VACCINES & PREVENTION BV4 citations68
US11896663B2Feb 13, 2024
Immunodeficiency virus type 1 (HIV-1) mutant envelope proteins
JANSSEN VACCINES & PREVENTION BV0 citations59
US10973907B2Apr 13, 2021
Recombinant adenoviruses encoding mosaic human immunodeficiency virus (HIV) Env, Gag, and Pol antigens
JANSSEN VACCINES & PREVENTION BV0 citations59
US11473105B2Oct 18, 2022
Potent and balanced bidirectional promoter
JANSSEN VACCINES & PREVENTION BV0 citations58
US11459583B2Oct 4, 2022
Adenovirus vectors and uses thereof
JANSSEN VACCINES & PREVENTION BV0 citations58
US11001858B2May 11, 2021
Potent and balanced bidirectional promoter
JANSSEN VACCINES & PREVENTION BV0 citations58
US12054737B2Aug 6, 2024
Potent and short promoter for expression of heterologous genes
JANSSEN VACCINES & PREVENTION BV0 citations57
US11034978B2Jun 15, 2021
Potent and short promoter for expression of heterologous genes
JANSSEN VACCINES & PREVENTION BV0 citations57
US10570417B2Feb 25, 2020
Recombinant adenovirus expressing two transgenes with a bidirectional promoter
JANSSEN VACCINES & PREVENTION BV0 citations46
US10517938B2Dec 31, 2019
Adenovirus based malaria vaccine encoding and displaying a malaria antigen
JANSSEN VACCINES & PREVENTION BV0 citations42